CORC

浏览/检索结果: 共25条,第1-10条 帮助

限定条件                
已选(0)清除 条数/页:   排序方式:
Randomised phase III trial of concurrent chemoradiotherapy with extended nodal irradiation and erlotinib in patients with inoperable oesophageal squamous cell cancer 期刊论文
2018, 卷号: 93, 页码: 99-107
作者:  Wu, Shi-Xiu;  Wang, Lv-Hua;  Luo, Hong-Lei
收藏  |  浏览/下载:8/0  |  提交时间:2020/01/03
Inhibition of miR-23a increases the sensitivity of lung cancer stem cells to erlotinib through PTEN/PI3K/Akt pathway 期刊论文
2017, 卷号: 38, 期号: 5, 页码: 3064-3070
作者:  Han, Zhijun;  Zhou, Xiaoyun;  Li, Shanqing;  Qin, Yingzhi;  Chen, Yeye
收藏  |  浏览/下载:5/0  |  提交时间:2020/01/03
A multicenter, randomized, open-label, phase II trial of erlotinib versus etoposide plus cisplatin with concurrent radiotherapy in unresectable stage III non-small cell lung cancer (NSCLC) with epidermal growth factor receptor (EGFR) activating m 会议论文
JOURNAL OF CLINICAL ONCOLOGY, 2017-05-20
作者:  Xing, Ligang;  Wu, Gang;  Wang, Lvhua;  Li, Jian-Cheng;  Wang, Jianhua
收藏  |  浏览/下载:3/0  |  提交时间:2020/01/04
A multicenter, randomized, open-label, phase II trial of erlotinib versus etoposide plus cisplatin with concurrent radiotherapy in unresectable stage III non-small cell lung cancer (NSCLC) with epidermal growth factor receptor (EGFR) activating m 期刊论文
2017, 卷号: 35
作者:  Xing, Ligang;  Wu, Gang;  Wang, Lvhua;  Li, Jian-Cheng;  Wang, Jianhua
收藏  |  浏览/下载:4/0  |  提交时间:2020/01/04
Recurrent Response to Advanced NSCLC with Erlotinib Developing Central Nervous System Failure during Gefitinib or Icotinib Treatment 期刊论文
2017, 卷号: 12, 期号: 11, 页码: S2127-S2128
作者:  Ma, D.;  Xing, P.;  Li, J.
收藏  |  浏览/下载:7/0  |  提交时间:2020/01/04
Concurrent Erlotinib and Radiation Therapy for Chemoradiation Therapy-Intolerant Esophageal Squamous Cell Carcinoma Patients: An Updated Result 会议论文
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2016-10-01
作者:  Zhai, Y. R.;  Hui, Z.;  Wang, J.;  Wang, X.;  Liang, J.
收藏  |  浏览/下载:4/0  |  提交时间:2020/01/04
Chronopharmacokinetics of Erlotinib and Circadian Rhythms of Related Metabolic Enzymes in Lewis Tumor-Bearing Mice 期刊论文
2016, 卷号: 41, 期号: 5, 页码: 627-635
作者:  Liu, Jiao;  Wang, Chun-Yan;  Ji, Song-Gang;  Xu, Xia;  Wang, Pei-Pei
收藏  |  浏览/下载:1/0  |  提交时间:2020/01/04
Concurrent Erlotinib and Radiation Therapy for Chemoradiation Therapy-Intolerant Esophageal Squamous Cell Carcinoma Patients: An Updated Result 期刊论文
2016, 卷号: 96, 期号: 2, 页码: E146-E146
作者:  Zhai, Y. R.;  Hui, Z.;  Wang, J.;  Wang, X.;  Liang, J.
收藏  |  浏览/下载:1/0  |  提交时间:2020/01/04
Final overall survival results from a randomised, phase III study of erlotinib versus chemotherapy as first-line treatment of EGFR mutation-positive advanced non-small-cell lung cancer (OPTIMAL, CTONG-0802) 期刊论文
2015, 卷号: 26, 期号: 9, 页码: 1877-1883
作者:  Zhou, C.;  Wu, Y. L.;  Chen, G.;  Feng, J.;  Liu, X.Q.
收藏  |  浏览/下载:2/0  |  提交时间:2020/01/04
Efficacy of erlotinib in previously treated patients with advanced non-small cell lung cancer: analysis of the Chinese subpopulation in the TRUST study 期刊论文
2015, 卷号: 45, 期号: 6, 页码: 569-575
作者:  Huang, Yisheng;  Zhang, Li;  Shi, Yuankai;  Ma, Shenglin;  Liao, Meilin
收藏  |  浏览/下载:2/0  |  提交时间:2020/01/13


©版权所有 ©2017 CSpace - Powered by CSpace